Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Influenza

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 99 articles: HTML format Text format

Single Articles

April 2010
1. WHITLEY RJ
   Of ferrets and humans: influenza pathogenesis.
   J Infect Dis. 2010;201:976-7.
   PubMed     Text format     Related articles   
   
   
   
2. VAN DEN BRAND JM , Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, et al
   Severity of Pneumonia Due to New H1N1 Influenza Virus in Ferrets Is Intermediate between That Due to Seasonal H1N1 Virus and Highly Pathogenic Avian Influenza H5N1 Virus.
   J Infect Dis. 2010;201:993-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. FRANCE AM , Jackson M, Schrag S, Lynch M, et al
   Household Transmission of 2009 Influenza A (H1N1) Virus after a School-Based Outbreak in New York City, April-May 2009.
   J Infect Dis. 2010;201:984-92.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2010
4. EPSTEIN MA , Reynaldo S, El-Amin AN
   Is smoking a risk factor for influenza hospitalization and death?
   J Infect Dis. 2010;201:794-5.
   PubMed     Text format     Related articles   
   
   
   February 2010
5. BASTIEN N , Antonishyn NA, Brandt K, Wong CE, et al
   Human Infection with a Triple-Reassortant Swine Influenza A(H1N1) Virus Containing the Hemagglutinin and Neuraminidase Genes of Seasonal Influenza Virus.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. HEDLUND M , Aschenbrenner LM, Jensen K, Larson JL, et al
   Sialidase-Based Anti-Influenza Virus Therapy Protects against Secondary Pneumococcal Infection.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   January 2010
7. LANDAVERDE JM , Danovaro-Holliday MC, Trumbo SP, Pacis-Tirso CL, et al
   Guillain-Barre Syndrome in Children Aged <15 Years in Latin America and the Caribbean: Baseline Rates in the Context of the Influenza A (H1N1) Pandemic.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. BAZ M , Abed Y, Simon P, Hamelin ME, et al
   Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. GUBAREVA LV , Fry AM
   Current Challenges in the Risk Assessment of Neuraminidase Inhibitor-Resistant Influenza Viruses.
   J Infect Dis. 2010.
   PubMed     Text format     Related articles   
   
   
   
10. DANIELS TL , Talbot TR
    Unmasking the Confusion of Respiratory Protection to Prevent Influenza-Like Illness in Crowded Community Settings.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles   
    
    
    
11. AIELLO AE , Murray GF, Perez V, Coulborn RM, et al
    Mask Use, Hand Hygiene, and Seasonal Influenza-Like Illness among Young Adults: A Randomized Intervention Trial.
    J Infect Dis. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
12. WACHECK V , Egorov A, Groiss F, Pfeiffer A, et al
    A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication-Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. WOO PC , Tung ET, Chan KH, Lau CC, et al
    Cytokine Profiles Induced by the Novel Swine-Origin Influenza A/H1N1 Virus: Implications for Treatment Strategies.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. KIM YC , Quan FS, Yoo DG, Compans RW, et al
    Enhanced Memory Responses to Seasonal H1N1 Influenza Vaccination of the Skin with the Use of Vaccine-Coated Microneedles.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. DE VLEESCHAUWER A , Van Poucke S, Braeckmans D, Van Doorsselaere J, et al
    Efficient Transmission of Swine-Adapted but Not Wholly Avian Influenza Viruses among Pigs and from Pigs to Ferrets.
    J Infect Dis. 2009;200:1884-1892.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. KOUDSTAAL W , Koldijk MH, Brakenhoff JP, Cornelissen LA, et al
    Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir.
    J Infect Dis. 2009;200:1870-1873.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. BERAN J , Vesikari T, Wertzova V, Karvonen A, et al
    Efficacy of Inactivated Split-Virus Influenza Vaccine against Culture-Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo-Controlled Trial.
    J Infect Dis. 2009;200:1861-1869.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. XIE H , Liu TM, Lu X, Wu Z, et al
    A Live Attenuated H1N1 M1 Mutant Provides Broad Cross-Protection against Influenza A Viruses, Including Highly Pathogenic A/Vietnam/1203/2004, in Mice.
    J Infect Dis. 2009;200:1874-1883.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. BAXTER R , Lee J, Fireman B
    Evidence of Bias in Studies of Influenza Vaccine Effectiveness in Elderly Patients.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
20. EISEN DP , McBryde ES
    Avoiding Guillan-Barre Syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
    J Infect Dis. 2009;200:1627-8.
    PubMed     Text format     Related articles   
    
    
    October 2009
21. FURUSE Y , Suzuki A, Shimizu M, Kishi M, et al
    Reassortment between Amantadine-Resistant and -Sensitive H1N1 Influenza A Viruses Generated an Amantadine-Sensitive Virus during the 2007-2008 Season.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. KOHUT ML , Sim YJ, Yu S, Yoon KJ, et al
    Chronic Exercise Reduces Illness Severity, Decreases Viral Load, and Results in Greater Anti-Inflammatory Effects than Acute Exercise during Influenza Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
23. MEMOLI MJ , Jagger BW, Dugan VG, Qi L, et al
    Recent Human Influenza A/H3N2 Virus Evolution Driven by Novel Selection Factors in Addition to Antigenic Drift.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
24. MOK KP , Wong CH, Cheung CY, Chan MC, et al
    Viral Genetic Determinants of H5N1 Influenza Viruses That Contribute to Cytokine Dysregulation.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. KAWACHI S , Luong ST, Shigematsu M, Furuya H, et al
    Risk Parameters of Fulminant Acute Respiratory Distress Syndrome and Avian Influenza (H5N1) Infection in Vietnamese Children.
    J Infect Dis. 2009;200:510-515.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. ISON MG
    Influenza in hospitalized adults: gaining insight into a significant problem.
    J Infect Dis. 2009;200:485-8.
    PubMed     Text format     Related articles   
    
    
    
27. LEE N , Chan PK, Hui DS, Rainer TH, et al
    Viral loads and duration of viral shedding in adult patients hospitalized with influenza.
    J Infect Dis. 2009;200:492-500.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. NEUZIL KM , Bright RA
    Influenza Vaccine Manufacture: Keeping Up with Change.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
29. REISINGER KS , Block SL, Izu A, Groth N, et al
    Subunit Influenza Vaccines Produced from Cell Culture or in Embryonated Chicken Eggs: Comparison of Safety, Reactogenicity, and Immunogenicity.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. SZYMCZAKIEWICZ-MULTANOWSKA A , Groth N, Bugarini R, Lattanzi M, et al
    Safety and Immunogenicity of a Novel Influenza Subunit Vaccine Produced in Mammalian Cell Culture.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. QIN G , Mao H, Zheng J, Sia SF, et al
    Phosphoantigen-Expanded Human gammadelta T Cells Display Potent Cytotoxicity against Monocyte-Derived Macrophages Infected with Human and Avian Influenza Viruses.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. EVANS D , Cauchemez S, Hayden FG
    "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, guillain-barre syndrome, and the detection of rare severe adverse events.
    J Infect Dis. 2009;200:321-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. HAYNES LM , Caidi H, Radu GU, Miao C, et al
    Therapeutic monoclonal antibody treatment targeting respiratory syncytial virus (RSV) G protein mediates viral clearance and reduces the pathogenesis of RSV infection in BALB/c mice.
    J Infect Dis. 2009;200:439-47.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
34. KING QO , Lei B, Harmsen AG
    Pneumococcal Surface Protein A Contributes to Secondary Streptococcus pneumoniae Infection after Influenza Virus Infection.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. BEIGEL JH , Voell J, Huang CY, Burbelo PD, et al
    Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
36. POLAND GA , Mulligan MJ
    The Imperative of Influenza Vaccines for Elderly Individuals-An Evolving Story.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
37. FALSEY AR , Treanor JJ, Tornieporth N, Capellan J, et al
    Randomized, Double-Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High-Dose and Standard-Dose Influenza Vaccine in Adults 65 Years of Age and Older.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. SZECSI J , Gabriel G, Edfeldt G, Michelet M, et al
    DNA Vaccination with a Single-Plasmid Construct Coding for Viruslike Particles Protects Mice against Infection with a Highly Pathogenic Avian Influenza A Virus.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
39. CAO J , Gong Y, Yin Y
    The Role Played by Interleukin-10 in Cytokine and Chemokine Dysregulation during Secondary Pneumococcal Pneumonia after Influenza.
    J Infect Dis. 2009;199:1555-6.
    PubMed     Text format     Related articles   
    
    
    
40. GOOSKENS J , Jonges M, Claas EC, Meijer A, et al
    Prolonged Influenza Virus Infection during Lymphocytopenia and Frequent Detection of Drug-Resistant Viruses.
    J Infect Dis. 2009;199:1435-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. VONG S , Ly S, Van Kerkhove MD, Achenbach J, et al
    Risk Factors Associated with Subclinical Human Infection with Avian Influenza A (H5N1) Virus-Cambodia, 2006.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. BRIAND S , Fukuda K
    Avian Influenza A (H5N1) Virus and 2 Fundamental Questions.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles   
    
    
    
43. ZHOU L , Liao Q, Dong L, Huai Y, et al
    Risk Factors for Human Illness with Avian Influenza A (H5N1) Virus Infection in China.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. TIENSIN T , Ahmed SS, Rojanasthien S, Songserm T, et al
    Ecologic Risk Factor Investigation of Clusters of Avian Influenza A (H5N1) Virus Infection in Thailand.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. FEDSON DS
    Was bacterial pneumonia the predominant cause of death in the 1918-1919 influenza pandemic?
    J Infect Dis. 2009;199:1408-9.
    PubMed     Text format     Related articles   
    
    
    April 2009
46. REED JL , Welliver TP, Sims GP, McKinney L, et al
    Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection.
    J Infect Dis. 2009;199:1128-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
47. KILBOURNE ED
    Commentary on fatalities in the 1918-1919 influenza pandemic.
    J Infect Dis. 2009;199:913.
    PubMed     Text format     Related articles   
    
    
    
48. MUBAREKA S , Lowen AC, Steel J, Coates AL, et al
    Transmission of influenza virus via aerosols and fomites in the guinea pig model.
    J Infect Dis. 2009;199:858-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. LIPATOV AS , Kwon YK, Pantin-Jackwood MJ, Swayne DE, et al
    Pathogenesis of H5N1 Influenza Virus Infections in Mice and Ferret Models Differs According to Respiratory Tract or Digestive System Exposure.
    J Infect Dis. 2009;199:717-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. KARRON RA , Callahan K, Luke C, Thumar B, et al
    A Live Attenuated H9N2 Influenza Vaccine Is Well Tolerated and Immunogenic in Healthy Adults.
    J Infect Dis. 2009;199:711-716.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
51. MUBAREKA S , Lowen AC, Steel J, Coates AL, et al
    Transmission of Influenza Virus via Aerosols and Fomites in the Guinea Pig Model.
    J Infect Dis. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
52. KARLSTROM A , Boyd KL, English BK, McCullers JA, et al
    Treatment with Protein Synthesis Inhibitors Improves Outcomes of Secondary Bacterial Pneumonia after Influenza.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. JACKSON LA
    Using Surveillance to Evaluate Influenza Vaccine Effectiveness.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles   
    
    
    
54. BELONGIA EA , Kieke BA, Donahue JG, Greenlee RT, et al
    Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004-2005 Season to the 2006-2007 Season.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. SKOWRONSKI DM , De Serres G, Dickinson J, Petric M, et al
    Component-Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006-2007.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. REED JL , Brewah YA, Delaney T, Welliver T, et al
    Macrophage impairment underlies airway occlusion in primary respiratory syncytial virus bronchiolitis.
    J Infect Dis. 2008;198:1783-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. LIN JT , Li CG, Wang X, Su N, et al
    Antibody Persistence after 2-Dose Priming and Booster Response to a Third Dose of an Inactivated, Adjuvanted, Whole-Virion H5N1 Vaccine.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. KREIJTZ JH , Suezer Y, de Mutsert G, van den Brand JM, et al
    Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. ABED Y , Baz M, Boivin G
    A Novel Neuraminidase Deletion Mutation Conferring Resistance to Oseltamivir in Clinical Influenza A/H3N2 Virus.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
60. CHEN Y , Qin K, Wu WL, Li G, et al
    Broad Cross-Protection against H5N1 Avian Influenza Virus Infection by Means of Monoclonal Antibodies that Map to Conserved Viral Epitopes.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. ESTRIPEAUT D , Torres JP, Somers CS, Tagliabue C, et al
    Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
    J Infect Dis. 2008;198:1435-43.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. FALSEY AR , Walsh EE, Capellan J, Gravenstein S, et al
    Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines- Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum-Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals.
    J Infect Dis. 2008;198:1317-1326.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
63. GILL MA , Long K, Kwon T, Muniz L, et al
    Differential Recruitment of Dendritic Cells and Monocytes to Respiratory Mucosal Sites in Children with Influenza Virus or Respiratory Syncytial Virus Infection.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SHINOFF JJ , O'Brien KL, Thumar B, Shaw JB, et al
    Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
    J Infect Dis. 2008;198:1007-15.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
65. KEITEL WA , Campbell JD, Treanor JJ, Walter EB, et al
    Safety and Immunogenicity of an Inactivated Influenza A/H5N1 Vaccine Given with or without Aluminum Hydroxide to Healthy Adults: Results of a Phase I-II Randomized Clinical Trial.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. BARRY JM , Viboud C, Simonsen L
    Cross-Protection between Successive Waves of the 1918-1919 Influenza Pandemic: Epidemiological Evidence from US Army Camps and from Britain.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. GOJI NA , Nolan C, Hill H, Wolff M, et al
    Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine after Priming with an Antigenic Variant.
    J Infect Dis. 2008;198:635-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. POLAND GA , Sambhara S
    Vaccines against Influenza A (H5N1): Evidence of Progress.
    J Infect Dis. 2008;198:629-631.
    PubMed     Text format     Related articles   
    
    
    August 2008
69. KEITEL WA , Atmar RL, Nino D, Cate TR, et al
    Increasing Doses of an Inactivated Influenza A/H1N1 Vaccine Induce Increasing Levels of Cross-Reacting Antibody to Subsequent, Antigenically Different, Variants.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. MORENS DM , Taubenberger JK, Fauci AS
    Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. MCCULLERS JA
    Planning for an Influenza Pandemic: Thinking beyond the Virus.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles   
    
    
    July 2008
72. HOLLAND D , Booy R, Looze FD, Eizenberg P, et al
    Intradermal Influenza Vaccine Administered Using a New Microinjection System Produces Superior Immunogenicity in Elderly Adults: A Randomized Controlled Trial.
    J Infect Dis. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. MCELHANEY JE , Dutz JP
    Better Influenza Vaccines for Older People: What Will It Take?
    J Infect Dis. 2008.
    PubMed     Text format     Related articles   
    
    
    
74. GIOIA C , Agrati C, Castilletti C, Capobianchi MR, et al
    Influenza pandemics, immune cross-reactivity, and pandemic control strategies.
    J Infect Dis. 2008;198:294-5.
    PubMed     Text format     Related articles   
    
    
    
75. LEE SM , Cheung CY, Nicholls JM, Hui KP, et al
    Hyperinduction of Cyclooxygenase-2-Mediated Proinflammatory Cascade: A Mechanism for the Pathogenesis of Avian Influenza H5N1 Infection.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
76. LEVIE K , Leroux-Roels I, Hoppenbrouwers K, Kervyn AD, et al
    An Adjuvanted, Low-Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross-Reactive Immune Responses in Healthy Adults.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. MILLER MA , Viboud C, Olson DR, Grais RF, et al
    Prioritization of Influenza Pandemic Vaccination to Minimize Years of Life Lost.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. LALOR PA , Webby RJ, Morrow J, Rusalov D, et al
    Plasmid DNA-Based Vaccines Protect Mice and Ferrets against Lethal Challenge with A/Vietnam/1203/04 (H5N1) Influenza Virus.
    J Infect Dis. 2008;197:1643-1652.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. NACHAMKIN I , Shadomy SV, Moran AP, Cox N, et al
    Anti-Ganglioside Antibody Induction by Swine (A/NJ/1976/H1N1) and Other Influenza Vaccines: Insights into Vaccine-Associated Guillain-Barre Syndrome.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. OHMIT SE , Victor JC, Teich ER, Truscon RK, et al
    Prevention of Symptomatic Seasonal Influenza in 2005-2006 by Inactivated and Live Attenuated Vaccines.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2008
81. HALASA NB , Gerber MA, Chen Q, Wright PF, et al
    Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants.
    J Infect Dis. 2008;197:1448-1454.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. BOLTZ DA , Rehg JE, McClaren J, Webster RG, et al
    Oseltamivir Prophylactic Regimens Prevent H5N1 Influenza Morbidity and Mortality in a Ferret Model.
    J Infect Dis. 2008;197:1315-1323.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2008
83. HOELSCHER MA , Singh N, Garg S, Jayashankar L, et al
    A Broadly Protective Vaccine against Globally Dispersed Clade 1 and Clade 2 H5N1 Influenza Viruses.
    J Infect Dis. 2008;197:1185-1188.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2008
84. SAITO R , Suzuki Y, Li D, Zaraket H, et al
    Increased Incidence of Adamantane-Resistant Influenza A(H1N1) and A(H3N2) Viruses During the 2006-2007 Influenza Season in Japan.
    J Infect Dis. 2008;197:630-632.
    PubMed     Text format     Related articles   
    
    
    
85. SKOWRONSKI DM , Tweed SA, De Serres G
    Rapid Decline of Influenza Vaccine-Induced Antibody in the Elderly: Is It Real, or Is It Relevant?
    J Infect Dis. 2008;197:490-502.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. HE XS , Holmes TH, Mahmood K, Kemble GW, et al
    Phenotypic Changes in Influenza-Specific CD8(+) T Cells after Immunization of Children and Adults with Influenza Vaccines.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. KAUFMAN JA
    China's heath care system and avian influenza preparedness.
    J Infect Dis. 2008;197 Suppl 1:S7-13.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. BARRETT R , Brown PJ
    Stigma in the time of influenza: social and institutional responses to pandemic emergencies.
    J Infect Dis. 2008;197 Suppl 1:S34-S7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. CAUSEY D , Edwards SV
    Ecology of avian influenza virus in birds.
    J Infect Dis. 2008;197 Suppl 1:S29-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. CHEN J , Chen SC, Stern P, Scott BB, et al
    Genetic strategy to prevent influenza virus infections in animals.
    J Infect Dis. 2008;197 Suppl 1:S25-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. THACKER E , Janke B
    Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.
    J Infect Dis. 2008;197 Suppl 1:S19-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. FINEBERG HV
    Preparing for avian influenza: lessons from the "swine flu affair".
    J Infect Dis. 2008;197 Suppl 1:S14-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. KLEINMAN AM , Bloom BR, Saich A, Mason KA, et al
    Avian and pandemic influenza: a biosocial approach. Introduction.
    J Infect Dis. 2008;197 Suppl 1:S1-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. BERNSTEIN DI , Edwards KM, Dekker CL, Belshe R, et al
    Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. PELTOLA V , Waris M, Osterback R, Susi P, et al
    Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections.
    J Infect Dis. 2008;197:382-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2008
96. ZANGWILL KM , Treanor JJ, Campbell JD, Noah DL, et al
    Evaluation of the Safety and Immunogenicity of a Booster (Third) Dose of Inactivated Subvirion H5N1 Influenza Vaccine in Humans.
    J Infect Dis. 2008;.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. ANDREASEN V , Viboud C, Simonsen L
    Epidemiologic characterization of the 1918 influenza pandemic summer wave in copenhagen: implications for pandemic control strategies.
    J Infect Dis. 2008;197:270-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2007
98. RENWICK N , Schweiger B, Kapoor V, Liu Z, et al
    A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany.
    J Infect Dis. 2007;196:1754-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. MOSCONA A
    CSI microbiology: emerging pathogens and a staged strategy for detection and discovery.
    J Infect Dis. 2007;196:1727-8.
    PubMed     Text format     Related articles   
    
    

Thank you for your interest in scientific medicine.

This E-mail is provided by AMEDEO through an unrestricted educational grant from www.InfluenzaWorld.com, a Roche service.

Amedeo is a Flying Publisher website.    Design: